Institute of Molecular Biology and Genetics, University of Valladolid and Spanish Research Council, Valladolid, Spain.
J Biol Chem. 2011 May 6;286(18):16186-96. doi: 10.1074/jbc.M110.198952. Epub 2011 Mar 14.
Abnormal vascular smooth muscle cell (VSMC) proliferation contributes to occlusive and proliferative disorders of the vessel wall. Salicylate and other nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit VSMC proliferation by an unknown mechanism unrelated to anti-inflammatory activity. In search for this mechanism, we have studied the effects of salicylate and other NSAIDs on subcellular Ca(2+) homeostasis and Ca(2+)-dependent cell proliferation in rat aortic A10 cells, a model of neointimal VSMCs. We found that A10 cells displayed both store-operated Ca(2+) entry (SOCE) and voltage-operated Ca(2+) entry (VOCE), the former being more important quantitatively than the latter. Inhibition of SOCE by specific Ca(2+) released-activated Ca(2+) (CRAC/Orai) channels antagonists prevented A10 cell proliferation. Salicylate and other NSAIDs, including ibuprofen, indomethacin, and sulindac, inhibited SOCE and thereby Ca(2+)-dependent, A10 cell proliferation. SOCE, but not VOCE, induced mitochondrial Ca(2+) uptake in A10 cells, and mitochondrial depolarization prevented SOCE, thus suggesting that mitochondrial Ca(2+) uptake controls SOCE (but not VOCE) in A10 cells. NSAIDs depolarized mitochondria and prevented mitochondrial Ca(2+) uptake, suggesting that they favor the Ca(2+)-dependent inactivation of CRAC/Orai channels. NSAIDs also inhibited SOCE in rat basophilic leukemia cells where mitochondrial control of CRAC/Orai is well established. NSAIDs accelerate slow inactivation of CRAC currents in rat basophilic leukemia cells under weak Ca(2+) buffering conditions but not in strong Ca(2+) buffer, thus excluding that NSAIDs inhibit SOCE directly. Taken together, our results indicate that NSAIDs inhibit VSMC proliferation by facilitating the Ca(2+)-dependent inactivation of CRAC/Orai channels which normally is prevented by mitochondria clearing of entering Ca(2+).
异常的血管平滑肌细胞 (VSMC) 增殖导致血管壁闭塞和增殖性疾病。水杨酸盐和其他非甾体抗炎药 (NSAIDs) 通过一种未知的、与抗炎活性无关的机制抑制 VSMC 增殖。为了寻找这种机制,我们研究了水杨酸盐和其他 NSAIDs 对大鼠主动脉 A10 细胞(一种新内膜 VSMC 的模型)细胞内钙稳态和钙依赖性细胞增殖的影响。我们发现 A10 细胞显示出储存操作的 Ca(2+) 内流 (SOCE) 和电压操作的 Ca(2+) 内流 (VOCE),前者在数量上比后者更为重要。特异性 Ca(2+) 释放激活的 Ca(2+) (CRAC/Orai) 通道拮抗剂抑制 SOCE 可防止 A10 细胞增殖。水杨酸盐和其他 NSAIDs,包括布洛芬、吲哚美辛和舒林酸,抑制 SOCE 从而抑制钙依赖性 A10 细胞增殖。SOCE,但不是 VOCE,诱导 A10 细胞线粒体 Ca(2+) 摄取,而线粒体去极化阻止 SOCE,因此表明线粒体 Ca(2+) 摄取控制 A10 细胞中的 SOCE(而不是 VOCE)。NSAIDs 使线粒体去极化并阻止线粒体 Ca(2+) 摄取,表明它们有利于 CRAC/Orai 通道的 Ca(2+) 依赖性失活。NSAIDs 还抑制了在已经确立线粒体控制 CRAC/Orai 的大鼠嗜碱性白血病细胞中的 SOCE。在弱 Ca(2+) 缓冲条件下,NSAIDs 会加速大鼠嗜碱性白血病细胞中 CRAC 电流的缓慢失活,但在强 Ca(2+) 缓冲下则不会,因此排除了 NSAIDs 直接抑制 SOCE。总之,我们的结果表明,NSAIDs 通过促进 CRAC/Orai 通道的 Ca(2+) 依赖性失活来抑制 VSMC 增殖,而正常情况下,线粒体清除进入的 Ca(2+) 会阻止这种失活。